Abstract
Despite the development of new technologies, transurethral resection of the prostate (TURP) is still considered the gold standard for surgical treatment of the benign prostate hyperplasia (BPH). In general, new minimally invasive treatments have not demonstrated better outcomes than TURP in evidence based medicine trials published to date, and should be reserved for patients who prefer to avoid surgery, who are unsuitable candidates for surgery or who no longer respond favorably to medication.
TUMT and TUNA appears to be more effective than medical therapy but less effective than TURP. Both treatments can be given under topical anesthesia or local prostatic or perineal block.
Efficacy of transurethral vaporization appears similar to TURP, but the studies are short-term and the glands operated on are relatively small. In patients with small prostates, the transurethral incision of the prostate can also be a good option, associated with less morbidity than TURP.
Bipolar resection of the prostate is similar to TURP in effectiveness, but the data are inconclusive regarding blood loss, length of catheterization and hospital stay.
Long-term comparative trials are needed to determine if the minimally invasive therapies are superior to standard TURP.
Similar content being viewed by others
References
Roehrborn CG, Bartsch G, Kirby R, et al (2001) Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology 58:642–650
Andersen JT, Nickel JC, Marshall VR, et al (1997) Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology 49:839–845
McConnell JD, Roehrborn CG, Bautista OM, et al (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349:2387–2398
McConnel JD, Barry MJ, Bruskewitz RE, et al (1994) Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin 8:1–17
Wheelahan J, Scott NA, Cartmill R, et al (2000) Minimally invasive non-laser thermal techniques for prostatectomy: a systematic review. BJU Int 86:977–988
D’Ancona FC, Francisca EA, Witjes WP, et al (1998) Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 81:259–264
Ahmed M, Bell T, Lawrence WT, et al (1997) Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J␣Urol 79:181–185
Hoffman RM, MacDonald R, Monga M, et al (2004) Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int 94:1031–1036
Dahlstrand C, Walden M, Geirsson G, et al (1995) Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year followup. Br J Urol 76:614–618
Norby B, Nielsen HV, Frimodt-Moller PC, et al (2002) Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 90:853–862
Wagrell L, Schelin S, Nordling J, et al (2002) Feedback microwave thermotherapy versus TURP for clinical BPH – a randomized controlled multicenter study. Urology 60:292–299
Floratos DL, Kiemeney LA, Rossi C, et al (2001) Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 165:1533–1538
Issa MM (1996) Transurethral needle ablation of the prostate: report of initial US clinical trial. J Urol 156:413–419
AUA. AUA Guideline on Management of Benign Prostatic Hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 170:530–547
Bruskewitz R, Issa MM, Roehrborn CG, et al (1998) A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 159:1588–1593
Issa MM, Myrick SE, Symbas NP (1998) The TUNA procedure for BPH: basic procedure and clinical results. Infect Urol 11:148–154
Hill B, Bel Ville W, Bruskewitz R, et al (2004) Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J␣Urol 171:2336–2340
Cimentepe E, Unsal A, Saglam R (2003) Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol 17:103–107
Campo B, Bergamaschi F, Corrada P, et al (1997) Transurethral needle ablation (TUNA) of the prostate: a clinical and urodynamic evaluation. Urology 49:847–850
Steele GS, Sleep DJ (1997) Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup. J Urol 158:1834–1838
Millard RJ, Harewood LM, Tamaddon K (1996) A study of the efficacy and safety of transurethral needle ablation (TUNA) for benign prostatic hyperplasia. Neurourol Urodyn 15:916–929
Boyle P, Robertson C, Vaughan ED, et al (2004) A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int 94:83–88
Chandrasekar P, Virdi JS (2001) Transurethral needle ablation of the prostate (TUNA) – a prospective study, six year follow-up. In: AUA Annual Meeting Clinical Abstracts. Lippincott, Williams & Wilkins
Schatzl G, Madersbacher S, Djavan B, et al (2000) Two-year results of transurethral resection of the prostate versus four ‹less invasive’ treatment options. Eur Urol 37:695–701
Ramon J, Lynch TH, Eardley I, et al (1997) Transurethral needle ablation of the prostate the treatment of benign prostatic hyperplasia: a collaborative multicentre study. Br J Urol 80:128–134
Montorsi F, Naspro R, Salonia A, et al (2004) Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 172:1926–1929
Kuntz RM, Ahyai S, Lehrich K, et al (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016
Tan AH, Gilling PJ, Kennett KM, et al (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostate hyperplasia in large glands (40 to 200 grams). J Urol 170:1270–1274
Gilling PJ, Mackey M, Cresswell M, et al (1999) Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol 62:1640–1644
Tooher R, Sutherland P, Costello A, et al (2004) A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 171:1773–1781
Muschter R, Whitfield H (1999) Interstitial laser therapy of benign prostatic hyperplasia. Eur Urol 35:147–154
Liedberg F, Adell L, Hagberg G, et al (2003) Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement – a prospective randomized study. Scand J Urol Nephrol 37:494–497
Tuhkanen K, Heino A, Ala-Opas M (1999) Contact laser prostatectomy compared to TURP in prostatic hyperplasia smaller than 40 ml. Six-month follow-up with complex urodynamic assessment. Scand J Urol Nephrol 33:31–34
Keoghane SR, Lawrence KC, Gray AM, et al (2000) A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up. BJU Int 85:74–78
Sengor F, Kose O, Yucebas E, et al (1996) A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: results of a 6-month follow-up. Br J Urol 78:398–400
Cowles RS 3rd, Kabalian JN, Childs S, et al (1995) A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 46:155–160
Gujral S, Abrams P, Donovan JL, et al (2000) A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol 164:59–64
Hoffman RM, MacDonald R, Wilt TJ (2004) Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev. CD001987
Hoffman RM, MacDonald R, Slaton JW, et al (2003) Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol 169:210–215
Poulakis V, Dahm P, Witzsch U, et al (2004) Transurethral electrovaporization vs transurethral resection for symptomatic prostatic obstruction: a meta-analysis. BJU Int 94:89–95
Nuhoglu B, Ayyildiz A, Fidan V, et al (2005) Transurethral electrovaporization of the prostate: is it any better than standard transurethral prostatectomy? 5-year follow-up. J Endourol 19:79–82
Larsen EH, Dorflinger T, Gasser TC, et al (1987) Transurethral incision versus transurethral resection of the prostate for treatment of benign prostatic hypertrophy: a preliminary report. Scand J Urol Nephrol 104:83–86
Dorflinger T, Jensen FS, Krarup T, et al (1992) Transurethral prostatectomy compared with incision of the prostate in the treatment of prostatism caused by small benign prostate glands. Scand J Urol Nephrol 26:333–338
Riehmann M, Knes JM, Heisey D, et al (1995) Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology 45:768–775
Saporta L, Aridogan IA, Erlich N, et al (1996) Objective and subjective comparison of transurethral resection, transurethral incision and balloon dilation of the prostate. Eur Urol 29:439–445
Jahnson S, Dalen M, Gustavsson G, et al (1998) Transurethral incision versus resection of the prostate for small to medium benign prostatic hyperplasia. Br J Urol 81:276–281
Yang Q, Peters TJ, Donovan JL, et al (2001) Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: a systematic review and meta-analysis of randomized controlled trials. J Urol 165:1526–1532
Starkman JS, Santucci RA (2005) Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int 95:69–71
Fung BT, li SK, Yu CF, et al (2005) Prospective randomized controlled trial comparing plasmakinetic vaporessection and conventional transurethral resection of the prostate. Asian J Surg 28:24–28
Singh H, Desai MR, Shrivastav P, et al (2005) Bipolar versus monopolar transurethral resection of prostate: randomized controlled trial. J Endourol 19:333–338
Yang S, Lin WC, Chang HK, et al (2004) Gyrus plasmasect: is it better than monopolar transurethral resection of prostate? Urol Int 73:258–261
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zani, E.L., Netto, N.R. Is the minimally invasive treatment as good as transurethral resection for benign prostatic hyperplasia?. Int Urol Nephrol 39, 161–168 (2007). https://doi.org/10.1007/s11255-006-9053-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-006-9053-1